Business

October 22, 2013

Oxygen Biotherapeutics stock soars after acquisition announcement

Oxygen Biotherapeutics stock rose 30 percent Tuesday after the Morrisville company announced that it is acquiring the rights to a cardiovascular drug for $4.8 million in stock and naming a new CEO.

Related content

Comments

Editor's Choice Videos